[Anti-cytokine treatment, newly developed].

Hironari Hanaoka, Tsutomu Takeuchi

Research output: Contribution to journalReview articlepeer-review


Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis that causes pain, loss of function and disability, and can significantly reduce health-related quality of life. Improved understanding of the pathogenesis has led to the development of new biologic treatments that target specific cytokines. Large randomized controlled trials (RCTs) have been conducted to show the efficacy of anti-TNF and IL-6. However, despite these treatments, some patients fail to respond to these therapies. Recently other anti-ctyokine treatments had been developed and introduced. Here, we discuss about new anti-cytokine treatments for RA.

Original languageEnglish
Pages (from-to)1253-1260
Number of pages8
JournalUnknown Journal
Issue number7
Publication statusPublished - 2013 Jul

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of '[Anti-cytokine treatment, newly developed].'. Together they form a unique fingerprint.

Cite this